Screening Buccal Smear to Identify Cytological Alterations Brought on by Hormone Therapy

Authors

  • Fadwa Mohammed Ebraheem El-Daein University
  • Alkhair Abd Almahmoud Idris Gharab Al Neel College
  • Mudather Elnoor Younis El-Daein University

DOI:

https://doi.org/10.62951/ijhsb.v1i4.111

Keywords:

Buccal Smear Screening, Cytology Changes, Hormone Therapy

Abstract

Objective: To assess the differences in buccal cytology changes caused by hormone therapy in Sudanese women with breast and endometrial malignancies by comparing wet fixed and air dry H&E stained buccal smear samples.  Method: The eight-month study period ran from October 2015 to May 2016. The practical inquiry began in November 2015, and during that time, data gathering, a literature review, and research script typing were completed. One hundred participants had buccal smear samples taken, and these were ready for H&E staining using a wet and dry procedure on women receiving hormone medication. Results: The wet method produced buccal smears with pathology that was 56% malignant, 34% inflammatory, and 10% normal; the dry method produced identical results. The wet method produced excellent (40%), very well (28%), well (20%), acceptable (8%) and bad (4%) affinity, which was in line with the results of the dry method. There were no appreciable variations in the pathology and affinity of the wet and dry-prepared buccal smears (P = 0.14 and 0.0011 > 0.05). The cancerous The pathology of wet and dry buccal smears was reported in 7.7%, 47.1%, and 95% of the smears obtained from patients who had been on hormonal therapy for less than three years, three to nine years, and more than nine years, respectively. Wet and dry smears were reported in 20%, 21.1%, and 88.5% of the smears obtained from patients who had been on hormonal therapy once, twice, or three times a day, respectively. Conclusion: The pathology of the buccal smears showed significant differences based on the frequency and duration of hormone therapy.

Downloads

Download data is not yet available.

References

Abu Eid, R., Sawair, F., Landini, G., & Saku, T. (2012). Age and the architecture of oral mucosa. Age, 34(3), 651–658. https://doi.org/10.1007/s11357-011-9261-1

Beral, V., Bull, D., & Reeves, G.; Million Women Study Collaborators. (2005). Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet, 365(9470), 1543–1551. https://doi.org/10.1016/s0140-6736(05)66455-0

Bitran, J. D., Samuel, B., Klein, L., Hanauer, S., Johnson, L., Martinec, J., & White, L. (2006). Random high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant, 17, 157–162.

Brace, M., & McCauley, E. (2012). Oestrogens and psychological well-being. Annals of Medicine, 29, 283–290.

Brizuela, M., & Winters, R. (2024). Histology, oral mucosa. In StatPearls. Treasure Island, FL: StatPearls Publishing.

Buccal mucosa and masticator space anatomy. (n.d.). Retrieved October 19, 2024, from University of Iowa website: https://medicine.uiowa.edu/iowaprotocols/buccal-mucosa-and-masticator-space-anatomy

Chen, X., Lu, Y., Chen, T., & Li, R. (2021). The female vaginal microbiome in health and bacterial vaginosis. Frontiers in Cellular and Infection Microbiology, 11. https://doi.org/10.3389/fcimb.2021.631972

Croley, T. E., & Miers, C. (1978). Epithelial changes in the oral mucosa resulting from a variation in hormone stimulus. Journal of Oral Medicine, 33(3), 86–89.

Dose, A. M. (2005). The symptoms experience of mucositis, stomatitis and xerostomia. Seminars in Oncology Nursing, 11, 248–255.

Eliasson, L., Carlén, A., Lain, M., & Birkhed, D. (2003). Minor gland and whole saliva in postmenopausal women using a low potency estrogen (oestriol). Archives of Oral Biology, 48, 511–517.

Forabosco, A., Criscuolo, M., Coukos, G., Uccelli, E., Weinstein, R., Spinato, S., & Volpe, A. (1992). Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surgery, Oral Medicine, and Oral Pathology, 73(5), 570–574. https://doi.org/10.1016/0030-4220(92)90100-5

Furness, S., Roberts, H., Marjoribanks, J., & Lethaby, A. (2012). Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. The Cochrane Library. https://doi.org/10.1002/14651858.cd000402.pub4

Gillenwater, A., Papadimitrakopoulou, V., & Richards-Kortum, R. (2006). Oral premalignancy: New methods of detection and treatment. Current Oncology Reports, 8(2), 146–154. https://doi.org/10.1007/s11912-006-0050-4

Gramling, R., Eaton, C. B., Rothman, K. J., Cabral, H., Silliman, R. A., & Lash, T. L. (2009). Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women. Epidemiology, 20(5), 752–756. https://doi.org/10.1097/ede.0b013e3181a71279

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. (2007). Combined estrogen–progestogen menopausal therapy. Oxford, England: International Agency for Research on Cancer.

Kamrani, P., & Sadiq, N. M. (2024). Anatomy, head and neck, oral cavity (mouth). In StatPearls. Treasure Island, FL: StatPearls Publishing.

Leimola-Virtanen, R., Helenius, H., & Laine, M. (1997). Hormone replacement therapy and some salivary antimicrobial factors in post- and perimenopausal women. Maturitas, 27(2), 145–151. https://doi.org/10.1016/s0378-5122(97)00024-8

Leimola-Virtanen, R., Pennanen, R., & Syrjänen, S. (2007). Estrogen response in buccal mucosa: A cytological and immunohistological assay. Maturitas, 27, 41–45.

Lopez, B. C., Perez, M. G., & Soriano, Y. J. (2011). Dental considerations in pregnancy and menopause. Journal of Clinical and Experimental Dentistry, 3, e135. https://doi.org/10.4317/jced.3.e135

Matthews, K. A. (1992). Myths and realities of the menopause. Psychosomatic Medicine, 54(1), 1–9. https://doi.org/10.1097/00006842-199201000-00001

Naidu, M. U. R., Ramana, G. V., Rani, P. U., Mohan, L. K., Suman, A., & Roy, P. (2004). Chemotherapy-induced and/or radiation therapy-induced oral mucositis: Complicating the treatment of cancer. Neoplasia, 6(5), 423–431. https://doi.org/10.1593/neo.04169

Pabich, W. L., Fihn, S. D., Stamm, W. E., Scholes, D., Boyko, E. J., & Gupta, K. (2003). Prevalence and determinants of vaginal flora alterations in postmenopausal women. The Journal of Infectious Diseases, 188(7), 1054–1058. https://doi.org/10.1086/378203

Patil, S. N., Kalburgi, N. B., Koregol, A. C., Warad, S. B., Patil, S., & Ugale, M. S. (2012). Female sex hormones and periodontal health: Awareness among gynecologists - A questionnaire survey. Saudi Dental Journal, 24, 99–104.

Pritchard, K. I. (2001). Hormone replacement in women with a history of breast cancer. The Oncologist, 6(4), 353–362. https://doi.org/10.1634/theoncologist.6-4-353

Squier, C. A., & Kremer, M. J. (2001). Biology of oral mucosa and esophagus. Journal of the National Cancer Institute Monographs, 2001(29), 7–15. https://doi.org/10.1093/oxfordjournals.jncimonographs.a003443

Tan, D. A., & Dayu, A. R. B. (2022). Menopausal hormone therapy: Why we should no longer be afraid of the breast cancer risk. Climacteric: The Journal of the International Menopause Society, 25(4), 362–368. https://doi.org/10.1080/13697137.2022.2035711

Tarkkila, L., Furuholm, J., Tiitinen, A., & Meurman, J. H. (2008). Oral health in premenopausal and early postmenopausal women from baseline to 2 years of follow-up with reference to hormone replacement therapy. Clinical Oral Investigations, 12, 271–277.

Tarkkila, L., Linna, M., Tiitinen, A., Lindqvist, C., & Meurman, J. H. (2001). Oral symptoms at menopause: The role of hormone replacement therapy. Oral Surgery, Oral Pathology, Oral Radiology, and Endodontics, 92, 276–280.

Thompson, I. O., van der Bijl, P., van Wyk, C. W., & van Eyk, A. D. (2001). A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Archives of Oral Biology, 46(12), 1091–1098. https://doi.org/10.1016/s0003-9969(01)00082-6

Volpe, A., Lucenti, V., Forabosco, A., Boselli, F., Latessa, A. M., & Pozzo, P. (2011). Oral discomfort and hormone replacement therapy in postmenopausal women. Maturitas, 13, 1–5.

Weiderpass, E., Adami, H.-O., Baron, J. A., Magnusson, C., Bergstrom, R., Lindgren, A., & Persson, I. (1999). Risk of endometrial cancer following estrogen replacement with and without progestins. Journal of the National Cancer Institute, 91(13), 1131–1137. https://doi.org/10.1093/jnci/91.13.1131

Wikipedia contributors. (2024, October 18). Hormone replacement therapy. Retrieved from Wikipedia, The Free Encyclopedia website: https://en.wikipedia.org/w/index.php?title=Hormone_replacement_therapy&oldid=1251931876

Zlotolow, I. M. (2008). General considerations in prevention and treatment of oral manifestation of cancer therapies. In A. P. Berget & D. E. Weissman (Eds.), Principles and practice of supportive oncology (pp. 1–20). Philadelphia, PA: Lippincott.

Published

2024-10-21

How to Cite

Fadwa Mohammed Ebraheem, Alkhair Abd Almahmoud Idris, & Mudather Elnoor Younis. (2024). Screening Buccal Smear to Identify Cytological Alterations Brought on by Hormone Therapy. International Journal of Health and Social Behavior, 1(4), 68–87. https://doi.org/10.62951/ijhsb.v1i4.111